Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endologix, a developer and manufacturer of minimally invasive treatments for vascular diseases, has appointed Gary Sorsher as vice president of quality, effective October 1, 2008.
Subscribe to our email newsletter
Mr Sorsher brings 20 years of quality assurance experience, including the past 15 years in medical devices with Bard Peripheral Vascular and Cordis, a Johnson & Johnson.
Most recently, Mr Sorsher served for two years as director of quality engineering at Bard Peripheral Vascular, where he oversaw quality assurance operations for Bard Peripheral Vascular and Bard Biopsy Systems.
John McDermott, president and CEO of Endologix, said: “We are adding another experienced industry veteran to our management team to provide additional depth and leadership to support our growth.
“Gary has developed and implemented effective quality and risk management systems both domestically and internationally, and has a proven track record for successfully introducing new products in the vascular market. He has a strong technical background and a hands-on leadership style that will be an exceptional fit with Endologix.”